| Wednesday 24 March |
| |
| Ardana Bioscience Ltd Satellite Symposium |
| 07.30-08.15 |
Alpha Room |
|
|
New therapies and latest thinking in male hypogonadism |
| |
| British Thyroid Association Pitt-Rivers Lecture |
| 08.30-09.15 |
Main Hall Chair: JH Lazarus (Cardiff) |
| S4 |
08.30 |
Are thyroid hormone receptors good or bad for you?
Samarut J (Lyon, France) |
| |
|
| COFFEE |
|
| 09.15-09.45 |
Main Foyer and Hewison Hall |
| |
| Symposium 7: Molecular basis of thyroid
disease |
| GENEROUSLY SUPPORTED BY JOURNAL OF ENDOCRINOLOGY AND CLINICAL
ENDOCRINOLOGY |
| 09.45-11.45 |
Main Hall Chair: JA Franklyn (Birmingham) |
| S27 |
09.45 |
Role of cytokines and lymphocytes in Graves' disease
Weetman AP (Sheffield) |
| |
|
|
| S28 |
10.15 |
Gene linkage and association studies in autoimmune thyroid disease
Gough SCL (Birmingham) |
|
|
|
| S29 |
10.45 |
Glycoprotein hormone receptors: from disease to structure and function
Vassart G (Brussels, Belgium) |
|
|
|
| S30 |
11.15 |
Thyroid cancer molecular genetics: new oncogenes offer potential therapeutic targets
Fagin JA (Cincinnati, OH, USA), Knauf JA, Croyle M, Nikiforov YE & Mitsutake
N |
|
|
|
| Symposium 8: Joint BES and EFES symposium: |
| Neuroactive steroids: implications for disease and healthy ageing |
| 09.45-11.45 |
Alpha Room Chairs: JC Buckingham (London) & W Wiersinga (Amsterdam, The
Netherlands) |
| S31 |
09.45 |
Effects of neuroactive steroids on myelination
Melcangi RC (Milan, Italy), Ballabio M, Gonzalez LC, Gyenes C, Leonelli
E & Magnaghi V |
|
|
|
| S32 |
10.15 |
Glial cells as mediators of the neuroprotective effects of oestrogen in the central
nervous system
Garcia-Segura LM (Madrid, Spain), Veiga S, Mendez P, Garcia-Ovejero D,
DonCarlos LL & Azcoitia I |
|
|
|
| S33 |
10.45 |
Oestrogen and stroke: the potential for harm as well as benefit
Macrae IM (Glasgow) |
|
|
|
| S34 |
11.15 |
Sexual dimorphism and neuroprotection by sex steroids in an animal model of
Parkinson's disease
Gillies GE (London), Murray HE, Dexter DT & McArthur SR |
|
|
|
| Oral Communication 5: Diabetes and metabolism |
| 09.45-11.45 |
Beta Room Chairs: AJ Bone (Brighton) & S Farooqi (Cambridge) |
| OC31 |
09.45 |
Inducing pancreatic beta cell regeneration; interactions of transcription factors and
peptide growth factors
Leadbeater WE, Thyssen S, Strutt B, Chamson A, Arany E, Pin C, Logan A & Hill
DJ |
|
|
WINNING ABSTRACT FROM THE 2003 BES AWARDS SUPPORTED BY PFIZER LTD |
| |
|
|
| OC32 |
10.00 |
Function of the calcium-sensing receptor in insulin-secreting MIN6 cells and human
islets of Langerhans
Squires PE, Gray E, Huang GC, Amiel SA, Persaud SJ & Jones PM |
| |
|
|
| OC33 |
10.15 |
Dietary intake and the IGF-system: a study in two related populations
with a markedly different dietary intake
Anderson SG, Heald AH, Vyas A, Siddals KW, Patel J, Laing I, Bhatnagar
D, Durrington P, Gibson JM & Cruickshank JK |
|
|
|
| OC34 |
10.30 |
POMC haploinsufficiency in mice can cause obesity and reduced adrenal function
Coll AP, Challis BG, Yeo GSH, Snell K & O'Rahilly S |
|
|
|
| OC35 |
10.45 |
Continuous subcutaneous administration of ghrelin results in accumulation
of adipose tissue, independent of hyperphagia or body weight gain
Wren AM, Small CJ, Thomas EL, Abbott CR, Ghatei MA, Bell JD & Bloom
SR |
|
|
|
| OC36 |
11.00 |
Tissue-specific alterations of glucocorticoid metabolism in ob/ob mice
Livingstone DEW, Packer SL, Kerr RC, Morton NM, Walker BR & Andrew
R |
|
|
|
| OC37 |
11.15 |
Resistin as an acute phase reactant and a positive mediator of IL-6 and
TNF-alpha secretion in isolated human subcutaneous adipocytes
Kusminski C, McTernan PG, Fisher FFM, Valsamakis G, Chetty R, Harte
AL & Kumar S |
|
|
|
| OC38 |
11.30 |
Bacterial and yeast co-expression studies reveal hexose-6-phosphate dehydrogenase
to be a regulator of 11beta-hydroxysteroid dehydrogenase type 1 oxoreductase
activity |
|
|
Walker OJ, Schneider SB, Edelstein M, Walker EA, Arlt W & Stewart PM |
|
|
NOVARTIS AWARD WINNER (NP2) ALSO PRESENTED IN A DEDICATED POSTER SESSION IN HEWISON
HALL ON TUESDAY 23 MARCH AT 12.30 |
|
|
|
| |
|
| LUNCH |
|
| 11.45-13.00 |
Main Foyer and Hewison Hall |
| |
| Attended Posters (odd numbers) |
| 12.00-13.00 |
Main Foyer and Hewison Hall |
| |
| British Thyroid Association Annual General Meeting |
| 11.45-13.00 |
Board Room |
| |
| Molecular Endocrinology Workshop: Mammalian RNAi |
| 13.00-14.00 |
Alpha Room Chair: K Chapman (Edinburgh) |
| S50 |
13.00 |
Mammalian RNA interference pathways |
|
|
McManus MT (Cambridge) & Sharp PA |
| |
| Novartis Pharmaceuticals UK Ltd Satellite Symposium |
| 13.00-14.00 |
Main Hall |
|
|
Consolidating the evidence base for somatostatin analogue therapy in
acromegaly and neuroendocrine tumours |
|
|
|
| Clinical Endocrinology Trust Lecture |
| 14.15-15.00 |
Main Hall Chair: JAH Wass (Oxford) |
| S5 |
14.15 |
Cycling into trouble |
|
|
Grossman AB (London) |
| |
|
|
| TEA |
|
|
| 15.00-15.30 |
Main Foyer and Hewison Hall |